STRATA CRITICAL MEDICAL, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $6.44 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-03
- STRATA CRITICAL MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $6.44M, a 1216.97% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $489.00K, a 91.10% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $5.49M.
- STRATA CRITICAL MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was -$122.88K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 7 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|
| 2025-12-31 | $6.44M 10-K · filed 2026-03-03 | |
| 2024-12-31 | $489.00K 10-K · filed 2025-03-13 | |
| 2023-12-31 | $5.49M 10-K · filed 2024-03-12 | |
| 2020-12-31 | -$122.88K 10-K/A · filed 2021-05-07 | |
| 2019-12-31 | $0.00 10-K/A · filed 2021-05-07 | $0.00 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |